Recommendations for the Use of Prolonged‐Release Fampridine in Patients with Multiple Sclerosis (MS)

Prolonged‐release fampridine (fampridine PR) is a potassium channel blocker that improves conductivity of signal on demyelinated axons in central nervous system. Fampridine PR has been approved to improve speed of walking in patients with multiple sclerosis. This statement provides a brief summary o...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:CNS Neurosci Ther
Asıl Yazarlar: Preiningerova, Jana Lizrova, Baumhackl, Ulf, Csepany, Tunde, Czaplinski, Adam, Deisenhammer, Florian, Derfuss, Tobias, Fabjan, Tanja H., Fazekas, Franz, Fuchs, Siegrid, Havrdova, Eva, Ledinek, Alenka Horvath, Illes, Zsolt, Jazbec, Sasa Sega, Klimova, Eleonora, Komoly, Samuel, Kurca, Egon, Linnebank, Michael, Lisy, Lubomir, Mares, Jan, Prochazkova, Lubica, Csilla, Rozsa, Szilasiova, Jarmila, Stourac, Pavel, Talab, Radomir, Turcani, Peter, Vachova, Marta, Vecsei, Laszlo, Vodusek, David, Zapletalova, Olga, Berger, Thomas
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2013
Konular:
Clinical Guidelines
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6493348/
https://ncbi.nlm.nih.gov/pubmed/23607697
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cns.12101
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller